Drug repurposing for COVID-19 using computational screening: Is Fostamatinib/R406 a potential candidate?
Sovan Saha, Anup Kumar Halder, Soumyendu Sekhar Bandyopadhyay, Piyali Chatterjee, Mita Nasipuri, Debdas Bose, Subhadip Basu
Topics & Concepts
Drug repositioningRepurposingDrugBankCoronavirus disease 2019 (COVID-19)Approved drugComputational biologyIn silicoRitonavirSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Drug developmentDrugMedicineComputer scienceVirologyBioinformaticsBiologyPharmacologyInfectious disease (medical specialty)DiseaseGeneticsViral loadGeneEcologyPathologyAntiretroviral therapyHuman immunodeficiency virus (HIV)Computational Drug Discovery MethodsSARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches